Vireo Growth (VREOF) Receivables - Net (2020 - 2026)
Vireo Growth's (VREOF) quarterly Receivables - Net came in at $14.1 million in Q1 2026, up 804.45% year-on-year from $1.6 million in Q1 2025, and up 1181.82% quarter-over-quarter from $1.1 million in Q4 2025.
Vireo Growth (VREOF) Receivables - Net (2020 - 2026) Analysis & Trends
Vireo Growth has disclosed Receivables - Net across 7 years of filings, most recently posting $14.1 million for Q1 2026.
- Receivables - Net for Q1 2026 came in at $14.1 million, up 804.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.1 million (up 804.45% YoY), and the FY2025 annual result was $1.1 million, down 28.83% from the prior year.
- Receivables - Net came in at $14.1 million for Q1 2026 at Vireo Growth, up from $1.1 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $14.1 million in Q1 2026 to a low of $655217.0 in Q4 2023.
- The 5-year median for Receivables - Net is $1.6 million (2023), against an average of $3.7 million.
- Across the five-year window, Receivables - Net soared 13712.15% in 2022 and slumped 83.19% in 2024, its largest moves.
- Vireo Growth's Receivables - Net stood at $1.4 million in 2022, then tumbled by 53.89% to $655217.0 in 2023, then jumped by 135.88% to $1.5 million in 2024, then slipped by 28.83% to $1.1 million in 2025, then soared by 1181.82% to $14.1 million in 2026.
- The last three Receivables - Net figures came in at $14.1 million (Q1 2026), $1.1 million (Q4 2025), and $11.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Vireo Growth | - | - | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.10 Mn |
| Mar 31, 2026 | 14.10 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 11.19 Mn |
| Sep 30, 2025 | 11.19 Mn |
| Jun 30, 2025 | 9.14 Mn |
| Jun 30, 2025 | 9.14 Mn |
| Mar 31, 2025 | 1.56 Mn |
| Mar 31, 2025 | 1.56 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Dec 31, 2024 | 1.55 Mn |
| Sep 30, 2024 | 2.85 Mn |
| Sep 30, 2024 | 2.85 Mn |
| Jun 30, 2024 | 1.95 Mn |
| Jun 30, 2024 | 1.95 Mn |
| Mar 31, 2024 | 716,458.00 |
| Mar 31, 2024 | 716,458.00 |
| Dec 31, 2023 | 655,217.00 |
| Dec 31, 2023 | 655,217.00 |